Quoin Secures EMA Orphan Drug Designation For QRX003 In Rare Skin Disorderrttnews·Oct 14, 2026 at 11:18 AM74907L4090.00%QNRX-3.23%
Quoin says EMA grants orphan drug designation for QRX003 in peeling skin syndromePUBT·Oct 14, 2026 at 10:30 AM74907L4090.00%QNRX-3.23%
This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mondaybenzinga_article·Oct 12, 2026 at 11:54 AM74907L4090.00%ASBH+1.11%
BTIG initiates coverage of Quoin Pharmaceuticals with Buy rating, $14 price targetTradingView·Oct 12, 2026 at 10:19 AM74907L4090.00%QNRX-3.23%
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga_article·Oct 7, 2026 at 09:06 PM74907L4090.00%DYAI-1.98%
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy | QNRX Stock NewsStockTitan·Oct 6, 2026 at 02:30 AM74907L4090.00%QNRX-3.23%
Quoin Pharmaceuticals Approves Executive Cash BonusesTip Ranks·Jun 4, 2025 at 08:40 PM74907L4090.00%QNRX-3.23%
